BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8940239)

  • 1. High prevalence of antibodies against circumsporozoite antigen of Plasmodium falciparum without development of symptomatic malaria in travelers returning from sub-Saharan Africa.
    Jelinek T; Löscher T; Nothdurft HD
    J Infect Dis; 1996 Dec; 174(6):1376-9. PubMed ID: 8940239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the incidence of infection with Plasmodium falciparum among international travelers.
    Jelinek T; Blüml A; Löscher T; Nothdurft HD
    Am J Trop Med Hyg; 1998 Jul; 59(1):35-7. PubMed ID: 9684623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroconversion to circumsporozoite antigen of Plasmodium falciparum demonstrates a high risk of malaria transmission in travelers to East Africa.
    Nothdurft HD; Jelinek T; Blüml A; von Sonnenburg F; Löscher T
    Clin Infect Dis; 1999 Mar; 28(3):641-2. PubMed ID: 10194093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of actual risk factors for malaria infection for travelers by means of measurement of circumsporozoite antibodies].
    Jelinek T; Nothdurft HD
    Wien Med Wochenschr; 1997; 147(19-20):471-4. PubMed ID: 9471846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for anti-circumsporozoite and anti-blood-stage antibodies for epidemiologic assessment of Plasmodium falciparum infection in travelers.
    Cobelens FG; Verhave JP; Leentvaar-Kuijpers A; Kager PA
    Am J Trop Med Hyg; 1998 Jan; 58(1):75-80. PubMed ID: 9452296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of malaria diagnosis in nonimmune travelers in endemic areas.
    Miranda IB; Weber C; Fleischmann E; Bretzel G; Löscher T
    J Travel Med; 2008; 15(6):426-31. PubMed ID: 19090797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers.
    Orlandi-Pradines E; Penhoat K; Durand C; Pons C; Bay C; Pradines B; Fusai T; Josse R; Dubrous P; Meynard JB; Durand JP; Migliani R; Boutin JP; Druilhe P; Rogier C
    Am J Trop Med Hyg; 2006 Jun; 74(6):979-85. PubMed ID: 16760507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to chemoprophylaxis and Plasmodium falciparum anti-circumsporozoite seroconversion in a prospective cohort study of Dutch short-term travelers.
    Belderok SM; van den Hoek A; Roeffen W; Sauerwein R; Sonder GJ
    PLoS One; 2013; 8(2):e56863. PubMed ID: 23451100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of anti-Plasmodium falciparum circumsporozoite repeat antibodies and rate of high malaria transmission in endemic areas of Rondonia State in northwestern Brazil.
    Oliveira-Ferreira J; Nakaie CR; Daniel-Ribeiro C
    Am J Trop Med Hyg; 1992 Jun; 46(6):720-6. PubMed ID: 1621896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circumsporozoite antibody as a serologic marker of Plasmodium falciparum transmission.
    Webster HK; Gingrich JB; Wongsrichanalai C; Tulyayon S; Suvarnamani A; Sookto P; Permpanich B
    Am J Trop Med Hyg; 1992 Oct; 47(4):489-97. PubMed ID: 1443348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum: use of a NANP19 antibody-test for the detection of infection in non-immune travellers.
    Knappik M; Peyerl-Hoffmann G; Jelinek T
    Trop Med Int Health; 2002 Aug; 7(8):652-6. PubMed ID: 12167092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Antibodies against Plasmodium falciparum Sporozoite Antigens as Predictive Disease Transmission Markers in an Area of Ghana with Seasonal Malaria Transmission.
    Kusi KA; Bosomprah S; Kyei-Baafour E; Dickson EK; Tornyigah B; Angov E; Dutta S; Dodoo D; Sedegah M; Koram KA
    PLoS One; 2016; 11(11):e0167175. PubMed ID: 27875594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum circumsporozoite antibody prevalence in Madagascar: a longitudinal study in three different epidemiologic areas.
    Romi R; Sabatinelli G; Majori G; Ralamboranto L; Raveloarifera F; Ranaivoharimina H
    Am J Trop Med Hyg; 1994 Dec; 51(6):856-63. PubMed ID: 7810823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-epitope chimeric antigen used as a serological marker to estimate Plasmodium falciparum transmission intensity in the border area of China-Myanmar.
    Yao MX; Sun XD; Gao YH; Cheng ZB; Deng WW; Zhang JJ; Wang H
    Infect Dis Poverty; 2016 Sep; 5(1):98. PubMed ID: 27604628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological cross-reactivities between the retroviruses HIV and HTLV-1 and the malaria parasite Plasmodium falciparum.
    Elm J; Desowitz R; Diwan A
    P N G Med J; 1998 Mar; 41(1):15-22. PubMed ID: 10741173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting.
    Dewasurendra RL; Dias JN; Sepulveda N; Gunawardena GS; Chandrasekharan N; Drakeley C; Karunaweera ND
    BMC Infect Dis; 2017 Jan; 17(1):49. PubMed ID: 28068925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective review of malaria cases seen in a non-endemic area of South Africa.
    Dube S; Ismail N; Hoosen AA
    Travel Med Infect Dis; 2008 Sep; 6(5):296-300. PubMed ID: 18760252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009.
    Wong J; Hamel MJ; Drakeley CJ; Kariuki S; Shi YP; Lal AA; Nahlen BL; Bloland PB; Lindblade KA; Were V; Otieno K; Otieno P; Odero C; Slutsker L; Vulule JM; Gimnig JE
    Malar J; 2014 Nov; 13():451. PubMed ID: 25416454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convalescent Plasmodium falciparum-specific seroreactivity does not correlate with paediatric malaria severity or Plasmodium antigen exposure.
    Kessler A; Campo JJ; Harawa V; Mandala WL; Rogerson SJ; Mowrey WB; Seydel KB; Kim K
    Malar J; 2018 Apr; 17(1):178. PubMed ID: 29695240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.